• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
CHEN Siliang,LIU Mengge,SHI Jinning,XU Xiaoqing,CAI Hongyan,HAN Weina.Prediction and validation of potential targets for Alzheimer's disease treatment using ferulic acid[J].Journal Of Pharmaceutical Research,2024,43(5):428-434[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2942times   Download 3305次 QR Code for this article
Scan with your phone!
阿魏酸治疗阿尔茨海默病的潜在靶点预测及验证
陈斯亮1,刘梦鸽1,史晋宁1,徐晓庆1,蔡红艳2,韩维娜1
Font:Larger+|Default|Smaller-
(1.邵阳学院普爱医学院<医学部>生理学教研室,湖南 邵阳 422000;2.山西医科大学基础医学院微生物与免疫教研室,山西 太原 030001)
摘要:
目的 利用生物信息学和分子生物学对阿魏酸在阿尔茨海默病(AD)治疗中的靶点进行预测,并研究其在AD中的疗效。方法 通过DisGeNET数据库和PubChem数据库获得AD与阿魏酸相互作用的共同基因;DAVID在线数据库对常见靶点进行GO/KEGG富集分析;利用STRING数据库建立蛋白互作网络筛选关键基因;通过免疫印记和酶联免疫吸附实验,对得到的关键基因的表达进行分析。结果 在确定了38个共同作用位点后,通过蛋白互作网络的构建确定了前三名的基因,分别是MMP9、TLR4和ACE。在免疫印迹实验和酶联免疫吸附实验中,阿魏酸下调MMP9、TLR4和ACE的表达(P<0.05)。结论 提示MMP9、TLR4和ACE可作为阿魏酸治疗AD的作用靶点。
关键词:  阿尔茨海默病  阿魏酸  生物信息学  基质金属蛋白酶9  Toll样受体4  血管紧张素转化酶
DOI:10.13506/j.cnki.jpr.2024.05.003
基金项目:国家自然科学基金面上项目(No.81271428);湖南省自然科学基金青年项目(No.2020JJ5517);湖南省教育厅科学研究项目(No.20C1671);国家级大学生创新创业训练项目(No.S202010547043)
Publication Date:May 25, 2024
Prediction and validation of potential targets for Alzheimer's disease treatment using ferulic acid
CHEN Siliang1,LIU Mengge1,SHI Jinning1,XU Xiaoqing1,CAI Hongyan2,HAN Weina1
(1. Department of Physiology, Puai Medical College (Medical College), Shaoyang University, Shaoyang 422000, China;2. Department of Microbiology and Immunology, School of Basic Medical Sciences, Shanxi Medical University, Taiyuan 030000, China)
Abstract:
Objective The potential targets of ferulic acid in the treatment of Alzheimer's disease (AD) were predicted using bioinformatics and molecular biology, and its efficacy in AD was investigated.Methods The methodology involved obtaining genes associated with the interaction between AD and ferulic acid from the DisGeNET and PubChem databases, conducting GO/KEGG enrichment analysis of common targets using the DAVID online database, and establishing a protein-protein interaction network to identify key genes through the STRING database; and analyzing the expression of key genes through immunoblot and enzyme-linked immunosorbent assays. Results After identifying 38 common interaction sites, the construction of a protein-protein interaction network revealed the top three genes, namely MMP9, TLR4, and ACE. In immunoblot and enzyme-linked immunosorbent assays, ferulic acid was found to downregulate the expression of MMP9, TLR4, and ACE (P<0.05). Conclusion The results suggest that MMP9, TLR4, and ACE may serve as therapeutic targets for ferulic acid in the treatment of AD.
Key words:  Alzheimer's disease  Ferulic acid  Bioinformatics  MMP9  TLR4  ACE
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.